A decrease in BTF3 by resveratrol, which controls cancer-associated gene transcription, could be pursued for inhibiting cell proliferation of adenocarcinoma of the esophagus, leading to the apoptosis of these cells, as seen in the molecular analysis in the present study. The gene discussed is BTF3; the disease is cancer.